SCHEMBL4899484

SCHEMBL4899484

CCN(Oc1ccc(-c2cocn2)c(C)c1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PTGDR Q13258 1/20 0.34
PPARG P37231 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
CYP2C9 P11712 1/20 0.33
MAPT P10636 3/20 0.33
RECQL P46063 1/20 0.33
IMPDH2 P12268 1/20 0.33
IMPDH1 P20839 1/20 0.33
KDM4E B2RXH2 3/20 0.32
HSD17B10 Q99714 1/20 0.32
POLB P06746 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4898318 0.91 POLB (0.37) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL4899473 0.80 TDP1 (0.42) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL4902618 0.75 ALDH1A1 (0.46) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL4906721 0.75 ALDH1A1 (0.46) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL4903045 0.75 ALDH1A1 (0.53) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL4909548 0.74 MMP9 (0.48) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL4907398 0.72 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2KMT2AMAPT
SCHEMBL4911887 0.71 ALDH1A1 (0.39) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL6529828 0.69 LMNA (0.35) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL4900658 0.68 ALDH1A1 (0.55) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885SMN1; SMN2 3271/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885SMN1; SMN2 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.